Both IL-4 and IL-13 receptors are also upregulated in the lesional skin of AD patients (24), suggesting that OSM suppress itch by promoting IL-4 and -13 responses and by concomitantly suppressing IL-31 responses in the DRG. The gene discussed is IL4; the disease is Alzheimer disease.